Breaking News Instant updates and real-time market news.

IMMU

Immunomedics

$17.22

0.07 (0.41%)

04:55
11/05/19
11/05
04:55
11/05/19
04:55

Immunomedics management to meet with Piper Jaffray

Meeting with Management to be held in Chicago on November 5 hosted by Piper Jaffray.

  • 05

    Nov

IMMU Immunomedics
$17.22

0.07 (0.41%)

08/20/19
08/20/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Immunomedics (IMMU) initiated with an Overweight at Cantor Fitzgerald. 2. PayPal (PYPL) initiated with a Buy at Rosenblatt while Square (SQ) was initiated with a Neutral. 3. Sunrun (RUN), Vivint Solar (VSLR), and Sunnova Energy (NOVA) initiated with an Overweight at KeyBanc. 4. Spotify (SPOT) initiated with an Equal Weight at Consumer Edge. 5. Silk Road Medical (SILK) initiated with a Buy at Argus. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/10/19
PIPR
09/10/19
NO CHANGE
PIPR
Overweight
Safety signals arise for potential Immunomedics competitor, says Piper Jaffray
Daiichi today reported updated Phase I data for its TROP2 antibody drug conjugate DS-1062 in non-small cell lung cancer, and while the drug's efficacy continues to impress, there do appear to be some safety signals popping up, Piper Jaffray analyst Joseph Catanzaro tells investors in a research note. Specifically, dose-limiting toxicities associated with skin rash/stomatitis were reported, which is notable as development of Pfizer's (PFE) TROP2 antibody drug conjugate was discontinued for excess skin rash and mucosa toxicity, adds the analyst. These data may or may not dampen concerns around DS-1062 being a competitive threat to Immunomedics' sacituzumab, says Catanzaro. However, he continues to believe Immunomedics is "very well-positioned" within triple-negative breast cancer and urothelial bladder cancer. The analyst reiterates an Overweight rating on the shares with a $20 price target. Following Daiichi's data, shares of Immunomedics are up 8% to $14.30.
09/10/19
JEFF
09/10/19
NO CHANGE
JEFF
Buy
Immunomedics competitor shows 'impressive' efficacy, AEs cause concern, says Jefferies
Jefferies analyst Chris Howerton says that Immunomedics competitor DS-1062 showed "impressive" efficacy of 70%-plus cORR at RP2D, but he notes that n=7 is "quite small," and baseline characteristics could be different. Importantly, the analyst points out that one patient died of respiratory failure, and four reported potential ILD since data cutoff, including one death. Overall, he does not view DS-1062 as near-term comparable to IMMU-132's current pipeline. Howerton reiterates a Buy rating and $22 price target on Immunomedics' shares.
09/29/19
PIPR
09/29/19
NO CHANGE
Target $20
PIPR
Overweight
Piper Jaffray says some may be disappointed by Immunomedics TROPHY response rate
Piper Jaffray analyst Joseph Catanzaro notes that Immunomedics (IMMU) presented interim data from the Phase II TROPHY study of sacituzumab govitecan in postchemo/CPI urothelial bladder cancer at ESMO. Overall, the response rate of 29% is consistent with prior Phase I data, but he does believe some could be disappointed by this number as it relates to Seattle Genetics' (SGEN) 44% ORR for EV. Catanzaro would await more mature data before drawing any definitive conclusions on the competitive positioning of sacituzumab and EV in post-chemo/IO UBC, but ultimately believes the SC ORR in a larger cohort is approvable and that both drugs will play important roles in this landscape. He reirerates an Overweight rating and $20 price target on Immunomedics's shares.

TODAY'S FREE FLY STORIES

GDX

VanEck Vectors Gold Miners ETF

$27.74

0.62 (2.29%)

15:30
12/11/19
12/11
15:30
12/11/19
15:30
Options
Gold bull lays out $2.4M for 100-day upside vertical »

Gold bull lays out $2.4M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIO

Rio Tinto

$57.10

1.03 (1.84%)

15:29
12/11/19
12/11
15:29
12/11/19
15:29
Downgrade
Rio Tinto rating change  »

Rio Tinto downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:20
12/11/19
12/11
15:20
12/11/19
15:20
General news
Powell: monetary policy isn't the right tool to react to near term volatility »

Powell: monetary policy…

NDSN

Nordson

$167.16

1.41 (0.85%)

15:19
12/11/19
12/11
15:19
12/11/19
15:19
Options
Nordson options imply 7.0% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
12/11/19
12/11
15:17
12/11/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
12/11/19
12/11
15:16
12/11/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$314.59

1.04 (0.33%)

, SPX

S&P 500

$0.00

(0.00%)

15:11
12/11/19
12/11
15:11
12/11/19
15:11
General news
Fed Chair says committee did not discuss impeachment proceedings »

Asked during his FOMC…

SPY

SPDR S&P 500 ETF Trust

$314.59

1.04 (0.33%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:05
12/11/19
12/11
15:05
12/11/19
15:05
General news
Powell believes passage of USMCA does remove some uncertainties »

Powell believes passage…

15:05
12/11/19
12/11
15:05
12/11/19
15:05
General news
Powell is pretty dovish on inflation »

Powell is pretty dovish…

15:05
12/11/19
12/11
15:05
12/11/19
15:05
General news
FX Action: USD-CAD »

FX Action: USD-CAD fell…

FTNW

FTE Networks

$1.37

-0.31 (-18.45%)

15:04
12/11/19
12/11
15:04
12/11/19
15:04
Hot Stocks
Breaking Hot Stocks news story on FTE Networks »

FTE Networks Inc trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRD

Tailored Brands

$4.96

-0.31 (-5.88%)

15:04
12/11/19
12/11
15:04
12/11/19
15:04
Options
Tailored Brands options imply 26.3% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

MGI

MoneyGram

$2.29

0.15 (7.01%)

15:02
12/11/19
12/11
15:02
12/11/19
15:02
Hot Stocks
MoneyGram extends partnership agreement with CVS for three years »

MoneyGram (MGI) announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$297.59

4.38 (1.49%)

, FOX

Fox Corp.

$35.40

0.47 (1.35%)

15:01
12/11/19
12/11
15:01
12/11/19
15:01
Periodicals
Judge prohibits Netflix from recruiting Fox executives, WSJ reports »

California judge Marc D.…

NFLX

Netflix

$297.59

4.38 (1.49%)

FOX

Fox Corp.

$35.40

0.47 (1.35%)

FOXA

Fox Corp.

$36.27

0.465 (1.30%)

DIS

Disney

$147.43

1.31 (0.90%)

NWS

News Corp

$13.61

0.15 (1.11%)

NWSA

News Corp.

$13.40

0.19 (1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

15:00
12/11/19
12/11
15:00
12/11/19
15:00
General news
Powell thinks year-end funding pressures in the repo market remain manageable »

Powell thinks year-end…

15:00
12/11/19
12/11
15:00
12/11/19
15:00
General news
Powell believes that empirically there is still a relationship between unemployment and inflation »

Powell believes that…

14:55
12/11/19
12/11
14:55
12/11/19
14:55
General news
FX Action: USD-JPY »

FX Action: USD-JPY was…

SPY

SPDR S&P 500 ETF Trust

$314.16

0.61 (0.19%)

, SPX

S&P 500

$0.00

(0.00%)

14:51
12/11/19
12/11
14:51
12/11/19
14:51
General news
Fed Chair says would need to see persistent move up in inflation to hike rates »

Fed Chairman Jerome…

SPY

SPDR S&P 500 ETF Trust

$314.16

0.61 (0.19%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:50
12/11/19
12/11
14:50
12/11/19
14:50
General news
Powell said there are conceptual similarities between 1995 and 1998 »

Powell said there are…

14:49
12/11/19
12/11
14:49
12/11/19
14:49
Conference/Events
Wolfe Research tech strategist to hold analyst/industry webcast »

Tech Strategist…

LULU

Lululemon

$233.70

4.14 (1.80%)

14:49
12/11/19
12/11
14:49
12/11/19
14:49
Options
Lululemon options imply 11.8% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

XLRN

Acceleron

$49.59

-0.9 (-1.78%)

14:47
12/11/19
12/11
14:47
12/11/19
14:47
Recommendations
Acceleron analyst commentary  »

Piper Jaffray sees strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

EVH

Evolent Health

$8.12

-0.87 (-9.68%)

14:45
12/11/19
12/11
14:45
12/11/19
14:45
Options
Evolent Health call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$32.08

0.13 (0.41%)

14:45
12/11/19
12/11
14:45
12/11/19
14:45
Recommendations
Horizon Pharma analyst commentary  »

Stifel confident in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 08

    Mar

14:45
12/11/19
12/11
14:45
12/11/19
14:45
General news
Fed Chair Powell said the economic outlook remains favorable »

Fed Chair Powell said the…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.